Navigation Links
Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference
Date:1/4/2011

press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements represent our management's judgment regarding future events.  The Company does not undertake any obligations to update any forward-looking statements whether as a result of new information, future events or otherwise.  Our actual results could differ materially from those discussed herein due to several factors including the success and timing of our clinical trials and our ability to obtain and maintain regulatory approval and labeling of our product candidates; our plans to develop and commercialize our product candidates; the loss of key scientific or management personnel; the size and growth of potential markets for our product candidates and our ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of our estimates regarding expenses, future revenues and capital requirements; our ability to obtain financing on terms acceptable to us; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers.  These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vaccinex, Inc. Initiates Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors
2. Zeus Expands Class 7 Capabilities to Include the Processing of Advanced Polymers
3. Teysuno™ (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer
4. Wiley-VCH launches new journal Advanced Energy Materials
5. Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany
6. Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo
7. StemCyte Awarded $488,950 for Advanced Therapeutic Applications of Umbilical Cord Blood Stem Cells from the Qualifying Therapeutic Discovery Project (QTDP)
8. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
9. ERC advanced grant for Professor Zandbergens nanolaboratory
10. IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project
11. Advanced Life Sciences Announces US Army Collaboration to Research and Develop Restanza for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... LONDON , May 21, 2015 ... your inner feelings - and those of others. Being ... and senses. Analyze and read people to anticipate their ... your deepest emotions and feelings to create unique ... generation of responsive games. Get inside a first-person-shooter as ...
(Date:5/21/2015)... 21, 2015 As part of its ... (BDWMC), Sun Health Foundation funded a $3.25 million project ... pharmacy with the most up-to-date features and technology. , ... The pharmacy's 45 staff members will begin moving from ... in the coming days. , The current pharmacy ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... the "Global Cell Therapy Market Outlook 2020 " ... cell therapy in tissue and regenerative medicine is expected ... other options which could help in the growth of ... segment but they are unable to form new tissue ...
Breaking Biology Technology:5 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... Nov. 8, 2010 DST Health Solutions, LLC, today ... claims administration platforms—Amisys Advance, PowerMHC, PowerMHS and PowerSTEPP. The ... Centers for Medicare & Medicaid Services (CMS). This change—from ... transaction standard—will be effective Jan. 1, 2012, as designated ...
... 2010 Neogen Corporation (Nasdaq: NEOG ) today ... (SE) has received approval from AOAC International. Neogen,s ... enteritidis , provides the egg industry with a quick, accurate ... Food and Drug Administration implements new SE-regulations. The AOAC,s process ...
... Nov. 8, 2010 Reportlinker.com announces that ... in its catalogue: Biomarkers ... and activities of leading players ... pharmaceuticals and biotechnology sectors are currently facing ...
Cached Biology Technology:HIPAA 5010 Ready: DST Health Solutions Launches Upgrades of Amisys Advance, PowerMHS, PowerMHC and PowerSTEPP 2HIPAA 5010 Ready: DST Health Solutions Launches Upgrades of Amisys Advance, PowerMHS, PowerMHC and PowerSTEPP 3Neogen's Rapid Test for Salmonella enteritidis Receives AOAC Approval 2Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 2Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 3Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 4Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 5Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 6Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 7Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 8Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players 9
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
(Date:4/13/2015)... April 13, 2015 According ... "Global Biometrics Market Forecast & Opportunities, 2020", the global ... of around 14% till 2020. The biometrics market ... scale implementation and review of biometric management systems. ... new products with greater efficiency, are resulting in ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... a world where we create over two quintillion bytes ... and government are grappling with the problem of how ... amount of information. To address the questions surrounding this ... Liebert, Inc., publishers ( http://www.liebertpub.com ) announces the launch ...
... norms of biofuel production. A commentary published today in ... gas (GHGs) emissions from bioenergy production are neglecting crucial ... benefits of biofuels compared to fossil fuels. ... of bioenergy production. Life Cycle Analysis (LCA) is a ...
... 12th International Coral Reef Symposium (ICRS 2012), the world,s ... years, will begin Monday, July 9, in Cairns, Queensland, ... policy makers, managers, and conservationists to present the latest ... the knowledge and findings presented during the symposium, daily ...
Cached Biology News:New peer-reviewed journal on big data launching in Fall 2012 2Environmental benefit of biofuels is overestimated, new study reveals 2Coral reef experts to present latest coral reef science during July symposium 2Coral reef experts to present latest coral reef science during July symposium 3
... DW4 liquid handling system from Molecular Devices ... in one instrument. The system handles a ... plate washing96-, 384- and 1536-welland is the ... DW4 has been optimized to dispense from ...
... 10 O 2 S 2 ... White crystalline powder Assay: greater than ... IR Melting Point: greater than or ... than or equal to 1% ...
... differences exist between the various commercial and ... slide used, the length and GC content ... the manufacturing protocol employed all influence the ... With all the different variables to ...
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...
Biology Products: